Clinical Trial Update: Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 safety study of GSK573719 in combination with tiotropium for chronic obstructive pulmonary disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719
• tiotropium (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2014-04-24